Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore
· Delayed Price · Currency is SGD · Price in USD 3.270
+0.080 (2.51%)
Mar 10, 2026, 11:50 AM SGT
SGX:T14 Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,153 | 3,870 | 4,118 | 3,547 | 4,133 | 2,267 | Upgrade
|
| Market Cap Growth | 28.62% | -6.01% | 16.09% | -14.17% | 82.27% | 29.44% | Upgrade
|
| Enterprise Value | 4,839 | 3,836 | 3,891 | 3,145 | 3,715 | 1,941 | Upgrade
|
| Last Close Price | 4.07 | 2.44 | 2.12 | 1.10 | 1.04 | 0.75 | Upgrade
|
| PE Ratio | 7.94 | 9.29 | 22.42 | 21.17 | 25.32 | 16.93 | Upgrade
|
| PS Ratio | 5.30 | 2.83 | 2.69 | 2.21 | 2.82 | 1.70 | Upgrade
|
| PB Ratio | 3.15 | 2.64 | 3.33 | 2.79 | 2.99 | 1.88 | Upgrade
|
| P/TBV Ratio | 3.26 | 2.75 | 3.56 | 2.96 | 3.16 | 2.00 | Upgrade
|
| P/FCF Ratio | 33.57 | 25.65 | 40.40 | 32.05 | 28.00 | 23.22 | Upgrade
|
| P/OCF Ratio | 30.00 | 22.39 | 32.13 | 26.94 | 22.85 | 16.68 | Upgrade
|
| EV/Sales Ratio | 4.88 | 2.81 | 2.54 | 1.96 | 2.53 | 1.45 | Upgrade
|
| EV/EBITDA Ratio | 26.04 | 22.97 | 22.06 | 20.58 | 24.96 | 14.51 | Upgrade
|
| EV/EBIT Ratio | 29.50 | 26.51 | 25.46 | 24.10 | 29.82 | 17.40 | Upgrade
|
| EV/FCF Ratio | 31.53 | 25.43 | 38.17 | 28.42 | 25.17 | 19.88 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.05 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.04 | 0.36 | 0.34 | 0.06 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.05 | 0.62 | 0.47 | 0.06 | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.19 | -0.50 | -0.28 | -0.40 | -0.36 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.71 | -4.37 | -1.95 | -3.38 | -3.35 | -2.94 | Upgrade
|
| Net Debt / FCF Ratio | -2.02 | -4.84 | -3.37 | -4.66 | -3.38 | -4.03 | Upgrade
|
| Asset Turnover | 0.48 | 0.70 | 0.81 | 0.86 | 0.80 | 0.82 | Upgrade
|
| Inventory Turnover | 1.31 | 2.67 | 3.09 | 3.38 | 2.76 | 2.61 | Upgrade
|
| Quick Ratio | 1.36 | 1.87 | 1.51 | 1.71 | 1.81 | 1.85 | Upgrade
|
| Current Ratio | 2.81 | 2.35 | 2.03 | 2.17 | 2.64 | 2.59 | Upgrade
|
| Return on Equity (ROE) | 46.11% | 30.56% | 14.68% | 13.37% | 12.63% | 11.85% | Upgrade
|
| Return on Assets (ROA) | 4.92% | 4.61% | 5.03% | 4.37% | 4.23% | 4.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.70% | 15.21% | 16.70% | 14.84% | 12.96% | 12.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 9.70% | 11.70% | 9.80% | 8.90% | 9.00% | Upgrade
|
| Earnings Yield | 12.59% | 10.77% | 4.46% | 4.72% | 3.95% | 5.91% | Upgrade
|
| FCF Yield | 2.98% | 3.90% | 2.48% | 3.12% | 3.57% | 4.31% | Upgrade
|
| Dividend Yield | 20.63% | 9.81% | 11.22% | 19.88% | 10.18% | 8.14% | Upgrade
|
| Payout Ratio | 28.19% | 45.33% | 88.91% | 44.96% | 30.17% | 35.15% | Upgrade
|
| Buyback Yield / Dilution | 0.33% | -0.07% | 0.71% | -0.94% | 0.04% | 0.37% | Upgrade
|
| Total Shareholder Return | 20.96% | 9.74% | 11.93% | 18.94% | 10.22% | 8.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.